News Medical
Ori Biotech Advances Cell and Gene Therapy with Digital PlatformPublished: 2026-07-14
OriBiotech
OriBiotech conducts cell and gene therapy (CGT) research, designed to automate CGT manufacturing.
Companies House ID
09757696
Incorporation Date
2015-09-02
Registered Name
Oribiotech Ltd
Status
Active
Employee Count
50-99
Valuation
£171.25 million
Registered Address
Mayde 5-10 Brandon Road
London
N7 9AA
London (Greater)
London
N7 9AA
London (Greater)
London
N7 9AA
Financials
Summary
| 06 / 2024 | 06 / 2023 | 06 / 2022 | 06 / 2021 | |
|---|---|---|---|---|
| Turnover | £0.00 | £0.00 | £0.00 | £0.00 |
| Operating Profit | £0.00 | £0.00 | £0.00 | £0.00 |
| EBITDA | £0.00 | £0.00 | £0.00 | £0.00 |
| Total Assets | £0.00 | £0.00 | £0.00 | £0.00 |
| Total Liabilities | £0.00 | £0.00 | £0.00 | £0.00 |
| Net Assets | £0.00 | £0.00 | £0.00 | £0.00 |
| Cash | £0.00 | £0.00 | £0.00 | £0.00 |
| Employee count | £0.00 | £0.00 | £0.00 | £0.00 |
Turnover over time
Fundraising
| Fundraising rounds | 5 |
|---|---|
| Amount Raised | £9.99m |
| Transaction | Investor/s | Amount | Stage | Date |
|---|---|---|---|---|
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
| 15th Jan 2024 | Undisclosed investors | £1.5M | Venture | 15/01/2024 |
Unlock the full company profile
Access our live, verified company data on the Beauhurst platform. To get access — and find out exactly what you're missing — get in touch.
Signals and Classifiers
Signals
Classifiers
SIC Codes (2007)
Industries
Key People
Alan Barge
Non-Executive Director
contact@company.comAndrew Gawman
Global Finance Director
contact@company.comArman Amini
Bioprocessing Director
contact@company.comBally Chima
Head of Talent & Recruitment
contact@company.comBarry Clare
Chairman
contact@company.comChris Mason
Co-Founder & Non-Executive Director
contact@company.comCourtney LeBlon
Technical Director, North America
contact@company.comDavid Smith
Vice President, Technical Operations
contact@company.comFarlan Veraitch
Co-Founder & Chief Scientific Officer
contact@company.comGilberto Cicero
Software Director
contact@company.comJason Foster
Chief Executive Officer & Executive Director
contact@company.comJason Jones
Chief Business Officer
contact@company.comEmployee count over time
News
Fierce Pharma
Cellares and Ori Lead in Cell Therapy AutomationPublished: 2026-06-18
Business Wire
Ori Biotech and ImmuXell Partner to Dose First Patient in Clinical TrialPublished: 2026-05-27
BioPharm
Panel Discusses Need for Flexibility and Scalability in CGT ManufacturingPublished: 2025-10-07
Fierce Pharma
Ori Biotech's Cell and Gene Platform Wins FDA Approval for Advanced ManufacturingPublished: 2025-09-03
Manufacturing Chemist Pharma
MaxCyte and Oribiotech Collaborate to Enhance Cell Therapy Manufacturing EfficiencyPublished: 2025-06-12
Contact
| Telephone | 020 0000 0000 |
| contact@company.com | |
| Website | https://oribiotech.com/ |
| Social Media |
Similar Companies
Unlock the full company profile
Access our live, verified company data on the Beauhurst platform. To get access — and find out exactly what you're missing — get in touch.